Annual accounts receivable:
$275.99M+$140.23M(+103.29%)Summary
- As of today (September 3, 2025), ASTH annual accounts receivable is $275.99 million, with the most recent change of +$140.23 million (+103.29%) on December 31, 2024.
- During the last 3 years, ASTH annual accounts receivable has risen by +$196.01 million (+245.06%).
- ASTH annual accounts receivable is now at all-time high.
Performance
ASTH Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$348.73M+$50.81M(+17.05%)Summary
- As of today (September 3, 2025), ASTH quarterly accounts receivable is $348.73 million, with the most recent change of +$50.81 million (+17.05%) on June 30, 2025.
- Over the past year, ASTH quarterly accounts receivable has increased by +$147.14 million (+72.99%).
- ASTH quarterly accounts receivable is now at all-time high.
Performance
ASTH Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ASTH Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +103.3% | +73.0% |
| 3 y3 years | +245.1% | +134.4% |
| 5 y5 years | +366.7% | +353.4% |
ASTH Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +245.1% | at high | +203.8% |
| 5 y | 5-year | at high | +390.1% | at high | +519.2% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ASTH Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $348.73M(+17.1%) |
| Mar 2025 | - | $297.92M(+7.9%) |
| Dec 2024 | $275.99M(+103.3%) | $275.99M(+32.2%) |
| Sep 2024 | - | $208.81M(+3.6%) |
| Jun 2024 | - | $201.59M(+10.5%) |
| Mar 2024 | - | $182.46M(+34.4%) |
| Dec 2023 | $135.76M(+18.3%) | $135.76M(-25.7%) |
| Sep 2023 | - | $182.84M(+22.1%) |
| Jun 2023 | - | $149.75M(-0.8%) |
| Mar 2023 | - | $150.88M(+31.5%) |
| Dec 2022 | $114.78M(+43.5%) | - |
| Dec 2022 | - | $114.78M(-28.5%) |
| Sep 2022 | - | $160.59M(+7.9%) |
| Jun 2022 | - | $148.79M(+13.0%) |
| Mar 2022 | - | $131.69M(+64.6%) |
| Dec 2021 | $79.98M(+42.0%) | $79.98M(+10.5%) |
| Sep 2021 | - | $72.38M(-15.2%) |
| Jun 2021 | - | $85.31M(+2.4%) |
| Mar 2021 | - | $83.32M(+47.9%) |
| Dec 2020 | $56.32M(-4.8%) | $56.32M(-5.8%) |
| Sep 2020 | - | $59.77M(-22.3%) |
| Jun 2020 | - | $76.92M(+11.6%) |
| Mar 2020 | - | $68.92M(+16.5%) |
| Dec 2019 | $59.14M(+4.8%) | $59.14M(+3.0%) |
| Sep 2019 | - | $57.44M(-28.9%) |
| Jun 2019 | - | $80.77M(+29.2%) |
| Mar 2019 | - | $62.53M(+10.8%) |
| Dec 2018 | $56.46M(+180.6%) | $56.46M(-19.3%) |
| Sep 2018 | - | $69.93M(+102.5%) |
| Jun 2018 | - | $34.54M(-34.6%) |
| Mar 2018 | - | $52.81M(+162.5%) |
| Dec 2017 | $20.12M | $20.12M(+314.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $4.86M(-10.4%) |
| Jun 2017 | - | $5.42M(-1.5%) |
| Mar 2017 | - | $5.51M(+62.3%) |
| Mar 2016 | $3.39M(-10.8%) | $3.39M(-7.2%) |
| Dec 2015 | - | $3.65M(-9.0%) |
| Sep 2015 | - | $4.02M(+8.7%) |
| Jun 2015 | - | $3.69M(-2.9%) |
| Mar 2015 | $3.80M(+151.8%) | $3.80M(+8.4%) |
| Dec 2014 | - | $3.51M(+4.1%) |
| Sep 2014 | - | $3.37M(+120.0%) |
| Jun 2014 | - | $1.53M(+1.4%) |
| Jan 2014 | $1.51M(-4.6%) | $1.51M(+2.3%) |
| Oct 2013 | - | $1.48M(+3.5%) |
| Jul 2013 | - | $1.43M(+8.0%) |
| Apr 2013 | - | $1.32M(-16.6%) |
| Jan 2013 | $1.58M(+59.2%) | $1.58M(+19.6%) |
| Oct 2012 | - | $1.32M(+32.6%) |
| Jul 2012 | - | $998.30K(-12.9%) |
| Apr 2012 | - | $1.15M(+15.3%) |
| Jan 2012 | $994.10K(+41.0%) | $994.10K(+12.3%) |
| Oct 2011 | - | $885.20K(+24.9%) |
| Jul 2011 | - | $708.60K(+2.3%) |
| Apr 2011 | - | $692.40K(-1.8%) |
| Jan 2011 | $705.00K(+54.1%) | $705.00K(+9.6%) |
| Oct 2010 | - | $643.10K(+3.3%) |
| Jul 2010 | - | $622.70K(-4.7%) |
| Apr 2010 | - | $653.70K(+42.9%) |
| Jan 2010 | $457.50K(+78.9%) | $457.50K(+9.8%) |
| Oct 2009 | - | $416.60K(+25.9%) |
| Jul 2009 | - | $331.00K(+23.0%) |
| Apr 2009 | - | $269.20K(+5.3%) |
| Jan 2009 | $255.70K | $255.70K(+69.4%) |
| Oct 2008 | - | $150.90K |
FAQ
- What is Astrana Health, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Astrana Health, Inc.?
- What is Astrana Health, Inc. annual accounts receivable year-on-year change?
- What is Astrana Health, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Astrana Health, Inc.?
- What is Astrana Health, Inc. quarterly accounts receivable year-on-year change?
What is Astrana Health, Inc. annual accounts receivable?
The current annual accounts receivable of ASTH is $275.99M
What is the all time high annual accounts receivable for Astrana Health, Inc.?
Astrana Health, Inc. all-time high annual accounts receivable is $275.99M
What is Astrana Health, Inc. annual accounts receivable year-on-year change?
Over the past year, ASTH annual accounts receivable has changed by +$140.23M (+103.29%)
What is Astrana Health, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of ASTH is $348.73M
What is the all time high quarterly accounts receivable for Astrana Health, Inc.?
Astrana Health, Inc. all-time high quarterly accounts receivable is $348.73M
What is Astrana Health, Inc. quarterly accounts receivable year-on-year change?
Over the past year, ASTH quarterly accounts receivable has changed by +$147.14M (+72.99%)